Clinical trial · Interventional
SONICS - Effectiveness of Specialist Oncology Nursing
A Study of the Effectiveness of Specialist Oncology Nursing Case Management in Improving Continuity of Supportive Cancer Care in the Community (SONICS)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research project will address the issue of gaps in continuity of supportive care for cancer patients during the early phases of the disease trajectory that result in unmet needs and unnecessary morbidity. The investigators intend to study the impact of a specialized cancer-nursing program, Interlink Community Cancer Nurses (Interlink) on patient outcomes. Impact will be assessed directly using a validated measure of continuity of care from the patients' perspective and validated measures of key supportive care patient outcomes including unmet needs, distress, uncertainty in illness, and quality of life, in a randomized trial.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Continuity of Care | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Community Interlink Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Difference in unmet supportive care needs between intervention and control group
- timeFrame
- 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
- measure
- Difference in continuity of care between intervention and control group
- timeFrame
- 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
- measure
- Difference in quality of life between intervention and control group
- timeFrame
- 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
Secondary outcomes (3)
- measure
- Difference in uncertainty in illness between intervention and control group
- timeFrame
- 2 to 3 weeks after baseline; 8 to 10 weeks after baseline
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed breast or colorectal cancer. * In the initial stages of surgical consultation within the randomized surgical practices. * Not had previous or concomitant malignancies (except for: non-melanoma skin cancer, or carcinoma in situ of the cervix). * Have been informed of cancer diagnosis by the surgical office. * Reside in the Interlink adult program service area. * Legally able to provide informed consent (18 years of age or older). * Able to speak and read English. * Patients from an intervention designated practice, must agree to referral to Interlink and to receiving an in-home needs assessment.
References
Publications (1)
- DERIVEDSussman J, Bainbridge D, Whelan TJ, Brazil K, Parpia S, Wiernikowski J, Schiff S, Rodin G, Sergeant M, Howell D. Evaluation of a specialized oncology nursing supportive care intervention in newly diagnosed breast and colorectal cancer patients following surgery: a cluster randomized trial. Support Care Cancer. 2018 May;26(5):1533-1541. doi: 10.1007/s00520-017-3981-4. Epub 2017 Nov 30. PMID 29189967